Fluoxetine hydrochloride, 99%
Fluoxetine hydrochloride, 99%
Fluoxetine hydrochloride, 99%
Fluoxetine hydrochloride, 99%
Thermo Scientific Chemicals

Fluoxetine hydrochloride, 99%

A selective serotonin reuptake inhibitor | CAS: 56296-78-7 | C17H19ClF3NO | 345.79 g/mol
Have Questions?
變更視圖buttonViewtableView
Quantity:
50 mg
250 mg
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
產品號碼 J61197.MD
亦稱為 J61197-MD
價格 (TWD)
-
申請報價
Quantity:
250 mg
Request bulk or custom format
化學識別
CAS56296-78-7
IUPAC Namehydrogen methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine chloride
Molecular FormulaC17H19ClF3NO
InChI KeyGIYXAJPCNFJEHY-UHFFFAOYNA-N
SMILES[H+].[Cl-].CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
檢視更多
規格Specification Sheet規格表
Appearance (Color)White
Assay from Supplier's CofA≥98.5% (HPLC)
FormCrystalline powder
Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor. It is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD).

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor. It is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD).

Solubility
Soluble in dimethylsulfoxide and water.

Notes
Incompatible with strong oxidizing agents.
RUO – Research Use Only

General References:

  1. Huang, C.; Seip, K. F.; Gjelstad, A.; Shen, X.; Pedersen-Bjergaard, S. Combination of Electromembrane Extraction and Liquid-Phase Microextraction in a Single Step: Simultaneous Group Separation of Acidic and Basic Drugs. Anal. Chem. 2015, 87 (13), 6951-6957.
  2. Chakravarty, P.; Kothari, S.; Deese, A.; Lubach. J. W. Solid-State Characterization of Novel Propylene Glycol Ester Solvates Isolated from Lipid Formulations. Mol. Pharmaceutics. 2015, 12 (7), 2551-2557.